首页> Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver> COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

导出 OA

翻译打印收藏纠错

第一作者： Frederic,Di Fiore

第一单位： Department of Hepatogastroenterology, Normandie Université, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, F 76000 Rouen, France. Electronic address: frederic.di-fiore@chu-rouen.fr.

作者： Frederic,Di Fiore ^[1] ; Olivier,Bouché ^[2] ; Come,Lepage ^[3] ; David,Sefrioui ^[4] ; Alice,Gangloff ^[4] ; Lilian,Schwarz ^[5] ; Jean Jacques,Tuech ^[5] ; Thomas,Aparicio ^[6] ; Thierry,Lecomte ^[7] ; Camille,Boulagnon-Rombi ^[8] ; Astrid,Lièvre ^[9] ; Sylvain,Manfredi ^[3] ; Jean Marc,Phelip ^[10] ; Pierre,Michel ^[11] ; Thésaurus National de Cancérologie Digestive (TNCD) ; Société Nationale Française de Gastroentérologie (SNFGE) ; Fédération Francophone de Cancérologie Digestive (FFCD) ; Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR) ; Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) ; Société Française de Chirurgie Digestive (SFCD) ; Société Française d'Endoscopie Digestive (SFED) ; Société Française de Radiothérapie Oncologique (SFRO) and Société Française de Radiologie (SFR) ; Association Chirurgie Hepato-Biliaire et Transplantation (ACHBT)

作者单位： Department of Hepatogastroenterology, Normandie Université, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, F 76000 Rouen, France. Electronic address: frederic.di-fiore@chu-rouen.fr. ^[1] Digestive Oncology, CHU Reims, University Reims Champagne Ardennes, France. ^[2] Hepato-Gastroenterology Department, University Hospital Le Bocage, EPICAD INSERM LNC-UMR 1231, Université de Bourgogne et Franche Comté, Dijon, France. ^[3] Department of Hepatogastroenterology, Normandie Université, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, F 76000 Rouen, France. ^[4] Department of Digestive Surgery, Normandie Université, UNIROUEN, Inserm U1245, IRON group, F 76000 Rouen, France. ^[5] Gastroenterology and Digestive Oncology, Saint Louis Hospital, APHP, Université de Paris, Paris, France. ^[6] Gastroenterology and Endoscopy Department, Trousseau Hospital, University F Rabelais Tours, France. ^[7] Pathology, CHU Reims, University Reims Champagne Ardennes, France. ^[8] Rennes 1 University, Rennes, France; Association pour le Dépistage des Cancers en Ille-et-Vilaine, ADECI35, Rennes, France; Department of Gastroenterology, CHU Pontchaillou, Rennes, France; INSERM UMR 1242, COSS "Chemistry, Oncogenesis, Stress Signaling", Rennes, France. ^[9] Department of Gastroenterology and Digestive Oncology, University Hospital of Saint Etienne, Saint Etienne, France. ^[10] Department of Hepatogastroenterology, Normandie Université, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, F 76000 Rouen, France. Electronic address: pierre.michel@chu-rouen.fr. ^[11]

关键词 COVID-19 infection Chemotherapy Digestive cancer French Clinical Practice Guidelines Surgery